Search clinical trials for: maximal tolerated dose
Total 21551 results
-
Sichuan Enray Pharmaceutical Sciences CompanyRecruitingCarbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor (CNSI-Fe(II))Cervical Cancer | Breast Cancer | Colorectal Cancer | Ovarian Cancer | Lung Cancer | Advanced Solid Tumor | Pancreas Cancer | Thyroid Cancer | Vulva CancerChina
-
Medical College of WisconsinNot yet recruiting
-
Beijing 302 HospitalNot yet recruitingHR+/HER2- Advanced Breast CancerChina
-
Medical College of WisconsinBarbara Ann Karmanos Cancer Institute; Cornerstone PharmaceuticalsRecruitingPancreas AdenocarcinomaUnited States
-
Zhuhai Yufan Biotechnologies Co., LtdRecruitingAdvanced Solid Tumor | Advanced Solid MalignanciesChina
-
AIO-Studien-gGmbHDeutsche Krebshilfe e.V., Bonn (Germany)RecruitingChemo-refractory Colorectal CarcinomaGermany
-
Zhuhai Yufan Biotechnologies Co., LtdRecruitingAdvanced Solid Tumor | Advanced Solid MalignanciesUnited States
-
Nimbus Saturn, Inc.Recruiting
-
EutilexRecruitingRenal Cell Carcinoma | Non-Small Cell Lung Cancer | Solid Tumor | Prostate Cancer | Renal Cell Cancer MetastaticUnited States, Korea, Republic of
-
Advenchen Laboratories Nanjing Ltd.Recruiting
-
University of Colorado, DenverRecruiting
-
Danae Hamouda, MDRecruitingAdvanced Solid Tumor | Advanced Pancreatic CancerUnited States
-
Institut BergoniéMerck Sharp & Dohme LLC; National Cancer Institute, France; Transgene; Fondation...RecruitingBreast Cancer | Soft-tissue Sarcoma | Solid TumorsFrance
-
National Cancer Institute (NCI)RecruitingSarcoma | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Neurofibroma, Plexiform | Leukemia, Promyelocytic, AcuteUnited States
-
King's College LondonGuy's and St Thomas' NHS Foundation TrustRecruiting
-
National Cancer Institute (NCI)Active, not recruitingNeurofibromatosis 1 | Neurofibroma, Plexiform | Neurofibromatosis Type 1 | NF1United States
-
M.D. Anderson Cancer CenterActive, not recruitingAdvanced CancersUnited States
-
University of Colorado, DenverActive, not recruitingHigh Grade Myelodysplastic SyndromesUnited States
-
University of Maryland, BaltimoreActive, not recruitingRelapsed or Refractory Acute Myeloid LeukemiaUnited States
-
Cedars-Sinai Medical CenterActive, not recruitingBrain MetastasesUnited States
-
Novartis PharmaceuticalsCompletedChronic Myelogenous Leukemia | Philadelphia Chromosome-positive Acute Lymphoblastic LeukemiaGermany, Australia, Netherlands, Spain, Korea, Republic of, France, Japan, Italy, Singapore, United States
-
University of Maryland, BaltimoreActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Eisai Co., Ltd.Active, not recruiting
-
Bliss Biopharmaceutical (Hangzhou) Co., LtdActive, not recruitingLocally Advanced/Metastatic HER2 Positive Solid TumorsChina, United States
-
M.D. Anderson Cancer CenterIncyte CorporationCompletedLeukemiaUnited States
-
Konkuk University Medical CenterChonbuk National University Hospital; Samsung Medical Center; Pusan National... and other collaboratorsActive, not recruitingSafety and Efficacy Study of Idarubicin Dose Intensification to Treat Acute Myeloid Leukemia (IDAML)Leukemia, Myeloid, AcuteKorea, Republic of
-
M.D. Anderson Cancer CenterMedImmune LLCTerminated
-
National Cancer Institute (NCI)TerminatedBreast Cancer | Brain Cancer | Brain MetastasisUnited States
-
Royal Marsden NHS Foundation TrustAstraZeneca; Cancer Research UK; RM/ICR Biomedical Research CentreActive, not recruitingSolid Tumour Refractory to Conventional TreatmentUnited Kingdom
-
University of NebraskaBristol-Myers SquibbCompleted
-
Memorial Sloan Kettering Cancer CenterStanford University; Juno Therapeutics, Inc.Active, not recruiting
-
Medical College of WisconsinMiltenyi Biomedicine GmbHActive, not recruitingB-cell Chronic Lymphocytic Leukemia | B-cell Non Hodgkin LymphomaUnited States
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyActive, not recruitingAcute Myeloid LeukaemiaUnited States, Australia, France, Spain
-
Emory UniversityCompletedLymphoblastic Lymphoma | Lymphoblastic LeukemiaUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedAdvanced Solid TumorsCanada, United States
-
Hellenic Institute for the Study of SepsisCompletedVirus Diseases | COVID-19 | Corona Virus Infection | Lower Respiratory Tract Infection ViralGreece
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedEsophageal Cancer | Non-Small Cell Lung Cancer | Metastatic Solid TumorsUnited States, Canada
-
Noxopharm LimitedTerminatedMetastatic Soft-tissue SarcomaUnited States
-
Noxopharm LimitedTerminatedMetastatic Castration-resistant Prostate Cancer and Other Solid TumorsUnited States
-
AbbVieGenentech, Inc.CompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Completed
-
Cornerstone PharmaceuticalsCompleted
-
Vanquish Oncology, Inc.University of Illinois at ChicagoTerminatedGlioblastoma Multiforme | Anaplastic AstrocytomaUnited States
-
Calgent Biotechnology Co., LtdCompletedResistant or Refractory Solid TumorsUnited States, Taiwan
-
Millennium Pharmaceuticals, Inc.CompletedDigestive System DiseaseUnited States
-
Grupo Espanol de Investigacion en SarcomasActive, not recruitingDrug Use | GIST | Drug Toxicity | Metastatic Adult Soft Tissue Sarcoma | Maximum Tolerated DoseSpain
-
University of Colorado, DenverCompletedPancreatic CancerUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)WithdrawnOsteosarcoma | Bone MetastasesUnited States
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLCTerminatedMetastatic Non-small-cell lunG CancerUnited Kingdom
-
Molecular Templates, Inc.TerminatedLeukemia, Lymphocytic, Chronic, B-Cell | Diffuse Large B Cell Lymphoma | Blood Cancer | Hematological Malignancy | Small Lymphocytic Leukemia | Non-Hodgkin's B-cell LymphomaUnited States, Canada, Georgia, Belarus, Spain, Israel, Moldova, Republic of, Poland, Serbia, Ukraine